2.27
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Regression analysis insights on Aytu BioPharma Inc. performanceEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Will Aytu BioPharma Inc. stock see insider buyingJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
What MACD signals say about Aytu BioPharma Inc.July 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Will Aytu BioPharma Inc. stock remain a Wall Street favorite2025 Top Decliners & Risk Controlled Daily Plans - newser.com
Aytu BioPharma Inc AY20 Stock Analysis and ForecastOptions Trading Strategies & Free Short-Term Trading Strategies - earlytimes.in
Real time social sentiment graph for Aytu BioPharma Inc.July 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
How to escape a deep drawdown in Aytu BioPharma Inc.Weekly Profit Summary & Risk Managed Investment Entry Signals - newser.com
Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulus2025 Retail Activity & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-10-31 04:46:09 - newser.com
Applying Elliott Wave Theory to Aytu BioPharma Inc.Trade Exit Summary & Weekly Breakout Watchlists - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investorsTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Understanding Aytu BioPharma Inc.’s price movementMarket Rally & Free Community Supported Trade Ideas - newser.com
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiplesFed Meeting & Weekly High Return Stock Forecasts - newser.com
Relative strength of Aytu BioPharma Inc. in sector analysisMarket Risk Analysis & Growth Focused Entry Reports - newser.com
There's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted Revenues Despite A 27% Share Price Rise - simplywall.st
How to interpret RSI for Aytu BioPharma Inc. stockWeekly Stock Analysis & Short-Term High Return Ideas - newser.com
Aytu’s EXXUA patent extended through 2030 for depression treatment By Investing.com - Investing.com Australia
Published on: 2025-10-29 04:11:29 - newser.com
Will Aytu BioPharma Inc. (AY20) stock announce a stock splitPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growth2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Published on: 2025-10-28 23:00:39 - newser.com
Aytu BioPharma (AYTU) Secures Patent Extension for EXXUA Till 20 - GuruFocus
Aytu’s EXXUA patent extended through 2030 for depression treatment - Investing.com
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM) - ACCESS Newswire
Aytu BioPharma (NASDAQ: AYTU) Extends EXXUA Patent Protection Through 2030 - Stock Titan
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Share Price Boosted 27% But Its Business Prospects Need A Lift Too - 富途牛牛
Does Aytu BioPharma Inc. qualify in momentum factor screeningTreasury Yields & Long-Term Growth Plans - newser.com
Published on: 2025-10-28 02:48:14 - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):